Physician

Sarah Ann Zeller, M.D.

According to 2025 Medicare claims, Sarah Zeller, M.D. (NPI: 1114066024) practices dermatology in the Charlottesville, VA market, with the plurality of this provider's patient population coming from Charlottesville City, VA. This provider's primary affiliated billing organization is DERMATOLOGY PLC (NPI: 1215018031; TIN: 541053168) and primary practice location at 22911-3569.

Zeller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,253 traditional Medicare patients, billed 7,224 HCPCS/CPT codes, and received $288,207 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 901 prescription claims across 379 beneficiaries totaling $120,030 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 3 records totaling $160. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $129,759 to $288,207. Similarly, Part D prescription costs have moved sharply higher in recent years, from $42,391 to $120,030. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$144K$288K2015 Medicare payment: $129,759 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $139,295 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $163,738 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $185,763 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $226,439 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $168,788 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $206,007 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $208,267 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $229,537 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $288,207 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158773,878$129,759
20168684,958$139,295
20179315,553$163,738
20189685,740$185,763
20191,0446,596$226,439
20209644,503$168,788
20218864,977$206,007
20228965,302$208,267
20239475,642$229,537
20241,2537,224$288,207

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$72K$145K2015 Drug cost: $42,391 (USD; Tot_Drug_Cst)2016 Drug cost: $46,731 (USD; Tot_Drug_Cst)2017 Drug cost: $144,711 (USD; Tot_Drug_Cst)2018 Drug cost: $121,240 (USD; Tot_Drug_Cst)2019 Drug cost: $103,071 (USD; Tot_Drug_Cst)2020 Drug cost: $60,068 (USD; Tot_Drug_Cst)2021 Drug cost: $67,498 (USD; Tot_Drug_Cst)2022 Drug cost: $93,039 (USD; Tot_Drug_Cst)2023 Drug cost: $130,488 (USD; Tot_Drug_Cst)2024 Drug cost: $120,030 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015245572$42,391
2016279607$46,731
2017257529$144,711
2018252571$121,240
2019305743$103,071
2020259577$60,068
2021247612$67,498
2022271622$93,039
2023293683$130,488
2024379901$120,030

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths417494$77
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,0601,558$60
11102Biopsy of related skin growth, first growth482595$60
17000Destruction of precancer skin growth, 1 growth635900$36
17003Destruction of precancer skin growth, 2-14 growths4572,616$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab15420$57,295
Clobetasol PropionateClobetasol Propionate852,622$3,005
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc912,607$1,286
FluorouracilFluorouracil15432$1,086
Triamcinolone AcetonideTriamcinolone Acetonide1123,861$1,029

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$160Galderma Laboratories, L.P.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sarah Ann Zeller, M.D.?

Tedicare shows public-source Medicare data for Sarah Ann Zeller, M.D. (NPI 1114066024), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarah Ann Zeller, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sarah Ann Zeller, M.D.?

Sarah Ann Zeller, M.D. is linked to DERMATOLOGY PLC (billing NPI 1215018031) in the available physician profile data.

Does Sarah Ann Zeller, M.D. have Open Payments data?

Sarah Ann Zeller, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.